How The Marsh & McLennan (MRSH) Investment Story Is Shifting With Mixed Analyst Signals
Marsh & McLennan Companies is under fresh scrutiny after a modest trim in its fair value estimate, with the target easing from about US$206.40 to roughly US$203.67, a move of around 1%. This adjustment sits alongside a mix of analyst views, where some see the recent share reset and balance sheet strength as appealing, while others point to AI related pressures and slower growth assumptions as reasons for reduced targets and more neutral stances. As you read on, you will see how these shifting...